Having a national diagnostic testing strategy would allow the US to cope more efficiently with the next pandemic, said Romney M. Humphries, PhD, D (ABMM), M (ASCP), professor of pathology ...

Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people ...

A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups of other conditions By Laura Landro Share Resize ...

An AI-based blood test devised by Johns Hopkins Kimmel Cancer Center has been proven to speed up pancreatic cancer treatment. Here are all the details. In what appears to be a major breakthrough ...

The Lumipulse blood test became the first “in vitro diagnostic device” to be endorsed by the U.S. Food and Drug Administration, which cleared it earlier this month as a new tool in diagnosing ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma ...

(RTTNews) - Hepion Pharmaceuticals, Inc. (HEPA), a clinical stage biopharmaceutical company, Wednesday said it has entered into a binding letter of intent (LOI) with New Day Diagnostics LLC, a ...

The diagnostic tests covered under the LOI represent a combined addressable market exceeding $15 billion. The Respiratory Panel RT-PCR Multiplex CE-IVD addresses a $5.6 billion market, growing at ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of metabolic dysfunction–associated steatotic liver disease (MASLD). The Elecsys ...

A $1M share purchase plan is also on the table, giving existing investors a shot at the action. ‘The funds will drive the US and Australian launch of our suite of diagnostic tests.’ ...

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV. With the ...

Last year, a record one million people underwent private health tests and diagnostic scans, with some providers reporting a 20 per cent surge in demand over the same period.